Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01859416Not ApplicableCompleted

Effects of Oral Nutritional Supplements in Nursing Home Residents

Role: collaborator

NCT02470013Not ApplicableCompleted

Medical and Health Economic Benefit of Oral Nutritional Supplements (ONS) in Ambulant Patients

Role: collaborator

NCT00687050Not ApplicableCompleted

Peroral Supplemental Nutrition in End-stage Renal Disease With and Without HIV Comorbidity

Role: collaborator

NCT00168987Phase 4Completed

Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors

Role: collaborator

All 4 trials loaded